(Q39705448)

English

The NK-1 receptor is expressed in human melanoma and is involved in the antitumor action of the NK-1 receptor antagonist aprepitant on melanoma cell lines

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

The NK-1 receptor is expressed in human melanoma and is involved in the antitumor action of the NK-1 receptor antagonist aprepitant on melanoma cell lines (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

author name string

Miguel Muñoz

1

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Marisa Rosso

2

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

María José Robles-Frias

3

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Manuel Vicente Salinas-Martín

4

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Rosario Rosso

5

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Ana González-Ortega

6

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Rafael Coveñas

7

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

publication date

10 May 2010

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Laboratory Investigation

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

90

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

1259-1269

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Substance P: a pioneer amongst neuropeptides

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.92

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.92

21 January 2018

Antitumoral action of the neurokinin-1 receptor antagonist L-733 060 on human melanoma cell lines

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.92

21 January 2018

A role for substance P in cancer promotion and progression: a mechanism to counteract intracellular death signals following oncogene activation or DNA damage

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.92

21 January 2018

Substance P activates responses correlated with tumour growth in human glioma cell lines bearing tachykinin NK1 receptors

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.92

21 January 2018

The NK1 receptor is involved in the antitumoural action of L-733,060 and in the mitogenic action of substance P on neuroblastoma and glioma cell lines

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.92

21 January 2018

Antitumoral action of the neurokinin-1-receptor antagonist L-733,060 and mitogenic action of substance P on human retinoblastoma cell lines

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.92

21 January 2018

NK-1 receptor antagonists induce apoptosis and counteract substance P-related mitogenesis in human laryngeal cancer cell line HEp-2.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.92

21 January 2018

The NK-1 receptor is expressed in human primary gastric and colon adenocarcinomas and is involved in the antitumor action of L-733,060 and the mitogenic action of substance P on human gastrointestinal cancer cell lines

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.92

21 January 2018

Substance P stimulates neovascularization in vivo and proliferation of cultured endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.92

21 January 2018

Induction of a metastatogenic tumor cell type by neurotransmitters and its pharmacological inhibition by established drugs

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.92

21 January 2018

Immunolocalization of full-length NK1 tachykinin receptors in human tumors

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.92

21 January 2018

Neurokinin-1 receptors located in human retinoblastoma cell lines: antitumor action of its antagonist, L-732,138.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.92

21 January 2018

Distinct mechanism for antidepressant activity by blockade of central substance P receptors

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.92

21 January 2018

The gerbil elevated plus-maze II: anxiolytic-like effects of selective neurokinin NK1 receptor antagonists

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.92

21 January 2018

Role of NK-1 and NK-2 tachykinin receptor antagonism on the growth of human breast carcinoma cell line MDA-MB-231.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.92

21 January 2018

Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.92

21 January 2018

Levels of p27(kip1) determine Aplidin sensitivity

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.92

21 January 2018

[D-Arg1, D-Phe5, D-Trp7,9, Leu11] substance P induces apoptosis in lung cancer cell lines in vitro

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.92

21 January 2018

Neurokinin 1 receptor mediates membrane blebbing in HEK293 cells through a Rho/Rho-associated coiled-coil kinase-dependent mechanism

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.92

21 January 2018

Stimulation of angiogenesis by substance P and interleukin‐1 in the rat and its inhibition by NK1 or interleukin‐1 receptor antagonists

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.92

21 January 2018

Enhancement of angiogenesis by endogenous substance P release and neurokinin-1 receptors during neurogenic inflammation

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.92

21 January 2018

Broad-spectrum G protein-coupled receptor antagonist, [D-Arg1,D-Trp5,7,9,Leu11]SP: a dual inhibitor of growth and angiogenesis in pancreatic cancer

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.92

21 January 2018

Cell motility through plasma membrane blebbing

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.92

21 January 2018

Neurokinin-1 receptor antagonists CP-96,345 and L-733,060 protect mice from cytokine-mediated liver injury

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.92

21 January 2018

Enantioselective inhibition of the formalin paw late phase by the NK1 receptor antagonist L-733,060 in gerbils

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.92

21 January 2018

Neurokinin-1 (NK-1) receptor antagonists abrogate methamphetamine-induced striatal dopaminergic neurotoxicity in the murine brain

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.92

21 January 2018

The neuropeptide/mast cell secretagogue substance P is expressed in cutaneous melanocytic lesions

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.92

7 January 2021

based on heuristic

inferred from DOI database lookup

Substance-P receptors in human primary neoplasms: tumoral and vascular localization

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.92

7 January 2021

based on heuristic

inferred from DOI database lookup

Neurokinin-1 receptor expression and its potential effects on tumor growth in human pancreatic cancer.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.92

7 January 2021

based on heuristic

inferred from DOI database lookup

The novel NK1 receptor antagonist MK-0869 (L-754,030) and its water soluble phosphoryl prodrug, L-758,298, inhibit acute and delayed cisplatin-induced emesis in ferrets

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.92

7 January 2021

based on heuristic

inferred from DOI database lookup

The NK-1 receptor antagonist aprepitant as a broad spectrum antitumor drug

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.92

7 January 2021

based on heuristic

inferred from DOI database lookup

Innervation and neurokinin receptors during angiogenesis in the rat sponge granuloma

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.92

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/LABINVEST.2010.92

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39705448&oldid=2203110680"